What is Millicom International Cellular S.A.'s earnings per share (EPS)?

Millicom International Cellular S.A. (TIGO) reported diluted earnings per share of $7.83 for fiscal year 2025. This represents a 429.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Millicom International Cellular S.A. (TIGO) Financials

TIGO

FY2025 annual

Revenue $5.8B +0.3% YoY

Net Income $1.4B +408.2% YoY

EPS (Diluted) $7.83 +429.1% YoY

Free Cash Flow $1.1B +2.0% YoY

Market Cap $15.3B as of Oct 6, 2026

Price / Sales 2.6x on $5.8B revenue, FY2025

Price / Earnings 11.2x on $1.4B net income, FY2025

Price / Book 4.2x on $3.6B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Mar 24, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Mar 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TIGO SEC filings page.

Millicom International Cellular S.A. (TIGO) reported $5.8B in revenue for fiscal year 2025, up 0.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TIGO FY2025 2026-10-04

Millicom's revenue is nearly flat, while 2025 earnings surged without matching cash growth as leverage and capital returns increased.

The 2025 earnings jump is not mirrored in cash: net income reached $1.36B, while free cash flow was $1.08B. Free cash flow was only $21M above FY2024's $1.06B, so reported profitability improved far more dramatically than cash generation after capital spending.

Revenue barely moved from $5.80B in FY2024 to $5.82B in 2025; this makes the higher cash generation a cash-conversion change rather than a volume story. Operating cash flow rose from $1.60B to $1.73B, but free cash flow stayed near $1.08B as capital spending increased to $650M.

Long-term debt rose to $2.29B in 2025. Debt-to-equity reached 0.6x, up from 0.2x in FY2024, while the current ratio was 0.9x, leaving current assets below current liabilities. The company also returned $882M through dividends and buybacks against $1.08B of free cash flow, so much of that year's cash generation was distributed rather than retained.

Financial Health Signals

Financial Health Score 31/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Millicom International Cellular S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Millicom International Cellular S.A., and counted as zero in the overall score.

Growth

Millicom International Cellular S.A.'s revenue grew a modest 0.3% year-over-year to $5.8B. This slow but positive growth earns a score of 35/100.

Leverage

Millicom International Cellular S.A. has a moderate D/E ratio of 0.63. This balance of debt and equity financing earns a leverage score of 56/100.

Liquidity

Millicom International Cellular S.A.'s current ratio of 0.88 is below the typical benchmark, resulting in a score of 14/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Millicom International Cellular S.A. converts 18.6% of revenue into free cash flow ($1.1B). This strong cash generation earns a score of 80/100.

Returns

Not available for Millicom International Cellular S.A., and counted as zero in the overall score.

Piotroski F-Score Partial

6/8

Millicom International Cellular S.A. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.27x

For every $1 of reported earnings, Millicom International Cellular S.A. generates $1.27 in operating cash flow ($1.7B OCF vs $1.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$1.6B

YoY+122.0%

QoQ+122.0%

Millicom International Cellular S.A. held $1.6B in cash against $2.3B in long-term debt as of Q4 2025.

Shares Outstanding

169M

YoY-1.8%

QoQ-1.8%

Millicom International Cellular S.A. had 169M shares outstanding in Q4 2025. This represents a decrease of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

TIGO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TIGO quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Revenue	$5.8B+0.3%	$5.8B+2.5%	$5.7B+0.7%	$5.6B+32.0%	$4.3B+12.0%	$3.8B-12.2%	$4.3B+9.9%	$3.9B+0.3%	$3.9B-2.6%	$4.0B
Interest Expense	$407.0M-9.4%	$449.0M-5.9%	$477.0M+9.9%	$434.0M+31.9%	$329.0M-10.8%	$369.0M+6.0%	$348.0M+48.7%	$234.0M-4.9%	$246.0M-6.1%	$262.0M
Income Tax	$303.0M+7.8%	$281.0M-33.7%	$424.0M+91.0%	$222.0M+40.5%	$158.0M+119.4%	$72.0M-40.0%	$120.0M+7.1%	$112.0M-30.9%	$162.0M-9.5%	$179.0M
Net Income	$1.4B+408.2%	$268.0M+209.4%	-$245.0M-289.9%	$129.0M-76.2%	$542.0M+240.8%	-$385.0M-350.0%	$154.0M+692.3%	-$26.0M-137.7%	$69.0M+176.7%	-$90.0M
EPS (Basic)	$7.86+427.5%	$1.49+398.0%	-$0.50-208.7%	$0.46-90.4%	$4.81+317.6%	-$2.21-340.2%	$0.92+300.0%	$0.23-14.8%	$0.27+325.0%	-$0.12
EPS (Diluted)	$7.83+429.1%	$1.48	-$0.50	$0.46	$4.79	-$2.20-339.1%	$0.92+300.0%	$0.23-14.8%	$0.27	-$0.12
Diluted Shares (Avg)	168M-2.6%	173M	171M	140M	129M	129M+27.5%	101M+0.3%	101M+0.4%	100M	100M

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

TIGO Balance Sheet

TIGO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Total Assets	$17.3B+25.6%	$13.7B-5.4%	$14.5B+2.2%	$14.2B-6.2%	$15.1B+21.9%	$12.4B-3.7%	$12.9B+25.0%	$10.3B+9.0%	$9.5B-1.7%	$9.6B
Current Assets	$3.0B+70.1%	$1.8B-8.5%	$1.9B-7.3%	$2.1B-8.3%	$2.3B-2.4%	$2.3B-13.0%	$2.7B+73.9%	$1.5B-3.8%	$1.6B	N/A
Cash & Equivalents	$1.6B+122.0%	$699.0M-9.8%	$775.0M-25.4%	$1.0B+16.1%	$895.0M+2.3%	$875.0M-24.8%	$1.2B+120.5%	$528.0M-14.7%	$619.0M-4.2%	$646.0M
Inventory	$70.0M+59.1%	$44.0M-2.2%	$45.0M-15.1%	$53.0M-15.9%	$63.0M+70.3%	$37.0M+15.6%	$32.0M-17.9%	$39.0M-13.3%	$45.0M	N/A
Goodwill	$4.3B+4.2%	$4.1B-0.3%	$4.1B+1.2%	$4.1B-1.0%	$4.1B+147.0%	$1.7B-1.5%	$1.7B+57.5%	$1.1B+78.5%	$599.0M-55.9%	$1.4B
Total Liabilities	$13.6B+34.1%	$10.2B-8.2%	$11.1B+4.8%	$10.6B-14.8%	$12.4B+22.2%	$10.1B-0.7%	$10.2B+35.8%	$7.5B+21.6%	$6.2B-1.2%	$6.3B
Current Liabilities	$3.4B+41.1%	$2.4B+3.2%	$2.3B+9.9%	$2.1B-52.8%	$4.5B+72.0%	$2.6B+7.9%	$2.4B-9.7%	$2.7B+34.5%	$2.0B	N/A
Non-Current Liabilities	$10.2B+45.2%	$7.0B-19.4%	$8.7B+3.5%	$8.4B+6.7%	$7.9B+5.0%	$7.5B-3.3%	$7.8B+60.9%	$4.8B+17.7%	$4.1B	N/A
Long-Term Debt	$2.3B+187.3%	$798.0M-6.6%	$854.0M+0.1%	$853.0M-14.4%	$996.0M+11.0%	$897.0M-9.2%	$988.0M	N/A	$3.8B	N/A
Total Equity	$3.6B+1.3%	$3.6B+3.7%	$3.4B-5.2%	$3.6B+32.6%	$2.7B+20.5%	$2.3B-15.1%	$2.7B-4.0%	$2.8B-14.9%	$3.3B-2.6%	$3.4B
Retained Earnings	N/A	N/A	N/A	N/A	$2.0B-14.6%	$2.4B+6.4%	$2.2B-12.3%	$2.5B-14.1%	$3.0B	N/A

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K
Total Assets	$17.3B+25.6%	$13.7B-5.4%	$14.5B+2.2%	$14.2B-6.2%	$15.1B+21.9%	$12.4B-3.7%	$12.9B+25.0%	$10.3B+9.0%
Current Assets	$3.0B+70.1%	$1.8B-8.5%	$1.9B-7.3%	$2.1B-8.3%	$2.3B-2.4%	$2.3B-13.0%	$2.7B+73.9%	$1.5B-3.8%
Cash & Equivalents	$1.6B+122.0%	$699.0M-9.8%	$775.0M-25.4%	$1.0B+16.1%	$895.0M+2.3%	$875.0M-24.8%	$1.2B+120.5%	$528.0M-14.7%
Inventory	$70.0M+59.1%	$44.0M-2.2%	$45.0M-15.1%	$53.0M-15.9%	$63.0M+70.3%	$37.0M+15.6%	$32.0M-17.9%	$39.0M-13.3%
Goodwill	$4.3B+4.2%	$4.1B-0.3%	$4.1B+1.2%	$4.1B-1.0%	$4.1B+147.0%	$1.7B-1.5%	$1.7B+57.5%	$1.1B+78.5%
Total Liabilities	$13.6B+34.1%	$10.2B-8.2%	$11.1B+4.8%	$10.6B-14.8%	$12.4B+22.2%	$10.1B-0.7%	$10.2B+35.8%	$7.5B+21.6%
Current Liabilities	$3.4B+41.1%	$2.4B+3.2%	$2.3B+9.9%	$2.1B-52.8%	$4.5B+72.0%	$2.6B+7.9%	$2.4B-9.7%	$2.7B+34.5%
Non-Current Liabilities	$10.2B+45.2%	$7.0B-19.4%	$8.7B+3.5%	$8.4B+6.7%	$7.9B+5.0%	$7.5B-3.3%	$7.8B+60.9%	$4.8B+17.7%
Long-Term Debt	$2.3B+187.3%	$798.0M-6.6%	$854.0M+0.1%	$853.0M-14.4%	$996.0M+11.0%	$897.0M-9.2%	$988.0M	N/A
Total Equity	$3.6B+1.3%	$3.6B+3.7%	$3.4B-5.2%	$3.6B+32.6%	$2.7B+20.5%	$2.3B-15.1%	$2.7B-4.0%	$2.8B-14.9%
Retained Earnings	N/A	N/A	N/A	N/A	$2.0B-14.6%	$2.4B+6.4%	$2.2B-12.3%	$2.5B-14.1%

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.

TIGO Cash Flow Statement

TIGO quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Operating Cash Flow	$1.7B+8.2%	$1.6B+31.1%	$1.2B-4.8%	$1.3B+34.3%	$956.0M+16.4%	$821.0M+2.5%	$801.0M+1.1%	$792.0M-3.4%	$820.0M-6.6%	$878.0M
Depreciation & Amortization	$1.3B+3.7%	$1.2B-7.8%	$1.3B-1.9%	$1.4B+14.0%	$1.2B-1.0%	$1.2B+8.7%	$1.1B+33.9%	$830.0M-5.6%	$879.0M-5.7%	$932.0M
Capital Expenditures	$650.0M+20.4%	$540.0M-33.7%	$814.0M+1.8%	$800.0M+8.1%	$740.0M+19.0%	$622.0M-15.5%	$736.0M+16.5%	$632.0M-2.8%	$650.0M-9.6%	$719.0M
Free Cash Flow	$1.1B+2.0%	$1.1B+159.9%	$409.0M-15.5%	$484.0M+124.1%	$216.0M+8.5%	$199.0M+206.2%	$65.0M-59.4%	$160.0M-5.9%	$170.0M+6.9%	$159.0M
Investing Cash Flow	-$374.0M+38.1%	-$604.0M+45.9%	-$1.1B-1.1%	-$1.1B+59.2%	-$2.7B-446.1%	-$495.0M+67.0%	-$1.5B-25.3%	-$1.2B-226.7%	-$367.0M+33.5%	-$552.0M
Financing Cash Flow	-$485.0M+54.5%	-$1.1B-182.8%	-$377.0M-37600.0%	-$1.0M-100.1%	$1.8B+397.2%	-$598.0M-144.1%	$1.4B+297.4%	$341.0M+173.5%	-$464.0M-5.2%	-$441.0M
Dividends Paid	$754.0M	$0	$0	$0	$0	$0-100.0%	$268.0M+0.8%	$266.0M+0.4%	$265.0M0.0%	$265.0M
Share Buybacks	$128.0M+77.8%	$72.0M+620.0%	$10.0M+233.3%	$3.0M-94.4%	$54.0M+237.5%	$16.0M+100.0%	$8.0M+33.3%	$6.0M+100.0%	$3.0M0.0%	$3.0M

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

TIGO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TIGO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Net Margin	23.4%+18.8pp	4.6%+8.9pp	-4.3%-6.6pp	2.3%-10.4pp	12.7%+22.8pp	-10.1%-13.7pp	3.5%+4.2pp	-0.7%-2.4pp	1.8%+4.0pp	-2.2%
Return on Equity	37.6%+30.1pp	7.5%+14.6pp	-7.1%-10.7pp	3.5%-16.2pp	19.8%+36.7pp	-16.9%-22.7pp	5.8%+6.7pp	-0.9%-3.0pp	2.1%+4.8pp	-2.7%
Return on Assets	7.9%+5.9pp	1.9%+3.6pp	-1.7%-2.6pp	0.9%-2.7pp	3.6%+6.7pp	-3.1%-4.3pp	1.2%+1.4pp	-0.3%-1.0pp	0.7%+1.7pp	-0.9%
Current Ratio	0.88+0.1x	0.73-0.1x	0.82-0.2x	0.97+0.5x	0.50-0.4x	0.88-0.2x	1.10+0.5x	0.57-0.2x	0.80	N/A
Debt-to-Equity	0.63+0.4x	0.220.0x	0.250.0x	0.23-0.1x	0.360.0x	0.390.0x	0.37-2.3x	2.69+1.5x	1.15-0.7x	1.86
Asset Turnover	0.34-0.1x	0.420.0x	0.390.0x	0.40+0.1x	0.280.0x	0.310.0x	0.340.0x	0.380.0x	0.420.0x	0.42
FCF Margin	18.6%+0.3pp	18.3%+11.1pp	7.2%-1.4pp	8.6%+3.5pp	5.1%-0.2pp	5.2%+3.7pp	1.5%-2.6pp	4.0%-0.3pp	4.3%+0.4pp	3.9%

Metric	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K	Q4'2010-K	Q4'1910-K	Q4'1810-K
Current Ratio	0.88+0.1x	0.73-0.1x	0.82-0.2x	0.97+0.5x	0.50-0.4x	0.88-0.2x	1.10+0.5x	0.57-0.2x
Debt-to-Equity	0.63+0.4x	0.220.0x	0.250.0x	0.23-0.1x	0.360.0x	0.390.0x	0.37-2.3x	2.69+1.5x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Note: The current ratio is below 1.0 (0.88), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Millicom International Cellular S.A. TIGO	FY2025	$5.8B	$1.4B	23.4%	$15.3B	31/100
Liberty Broadband Corporation LBRDK	FY2025	N/A	-$2.7B	N/A	$5.2B	—
Frontier Communications Parent, Inc. FYBR	FY2024	$5.9B	-$322.0M	-5.4%	$9.6B	29/100
Liberty Broadband Corporation LBRDA	FY2025	N/A	-$2.7B	N/A	$5.2B	—

Where Millicom International Cellular S.A. Ranks

Frequently Asked Questions

What is Millicom International Cellular S.A.'s annual revenue?

Millicom International Cellular S.A. (TIGO) reported $5.8B in total revenue for fiscal year 2025. This represents a 0.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Millicom International Cellular S.A.'s revenue growing?

Millicom International Cellular S.A. (TIGO) revenue grew by 0.3% year-over-year, from $5.8B to $5.8B in fiscal year 2025.

Is Millicom International Cellular S.A. profitable?

Yes, Millicom International Cellular S.A. (TIGO) reported a net income of $1.4B in fiscal year 2025, with a net profit margin of 23.4%.

How much debt does Millicom International Cellular S.A. have?

As of fiscal year 2025, Millicom International Cellular S.A. (TIGO) had $1.6B in cash and equivalents against $2.3B in long-term debt.

What is Millicom International Cellular S.A.'s net profit margin?

Millicom International Cellular S.A. (TIGO) had a net profit margin of 23.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Millicom International Cellular S.A.'s return on equity (ROE)?

Millicom International Cellular S.A. (TIGO) has a return on equity of 37.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Millicom International Cellular S.A.'s free cash flow?

Millicom International Cellular S.A. (TIGO) generated $1.1B in free cash flow during fiscal year 2025. This represents a 2.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Millicom International Cellular S.A.'s operating cash flow?

Millicom International Cellular S.A. (TIGO) generated $1.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Millicom International Cellular S.A.'s total assets?

Millicom International Cellular S.A. (TIGO) had $17.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Millicom International Cellular S.A.'s capital expenditures?

Millicom International Cellular S.A. (TIGO) invested $650.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Millicom International Cellular S.A. buy back shares?

Yes, Millicom International Cellular S.A. (TIGO) spent $128.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Millicom International Cellular S.A. have outstanding?

Millicom International Cellular S.A. (TIGO) had 169M shares outstanding as of fiscal year 2025.

What is Millicom International Cellular S.A.'s current ratio?

Millicom International Cellular S.A. (TIGO) had a current ratio of 0.88 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Millicom International Cellular S.A.'s debt-to-equity ratio?

Millicom International Cellular S.A. (TIGO) had a debt-to-equity ratio of 0.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Millicom International Cellular S.A.'s return on assets (ROA)?

Millicom International Cellular S.A. (TIGO) had a return on assets of 7.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Millicom International Cellular S.A.'s P/E ratio?

Millicom International Cellular S.A. (TIGO) trades at 11.2x earnings, its market capitalization divided by net income of $1.4B net income, FY2025. The market capitalization is $15.3B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Millicom International Cellular S.A.'s price-to-sales ratio?

Millicom International Cellular S.A. (TIGO) trades at 2.6x sales, its market capitalization divided by revenue of $5.8B revenue, FY2025. The market capitalization is $15.3B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Millicom International Cellular S.A.'s Piotroski F-Score?

Millicom International Cellular S.A. (TIGO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Millicom International Cellular S.A.'s earnings high quality?

Millicom International Cellular S.A. (TIGO) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Millicom International Cellular S.A.?

Millicom International Cellular S.A. (TIGO) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.